DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Colombel JF, Sandborn WJ, Rutgeerts P et al.
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Gastroenterology 2007;
132: 52-65
We do not assume any responsibility for the contents of the web pages of other providers.